tirzepatide for addiction Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds | Weight-loss drugs Eli Lilly to test its

Biol Trace Elem Res (2011) 141:17083

Gain high value access and increase the profitability of your brands

Whole milk compared with reduced-fat milk and childhood overweight: a systematic review and meta-analysis

It also expects prices to decline by 40 to 50% in FY27 and by a further 10 to 30% in FY28 as competition intensifies.

And the two market leaders are not standing still either: Novo has initiated a pipeline expansion program across six trials spanning obesity, sleep apnoea, and knee osteoarthritis, while Lilly is studying Foundayo for type 2 diabetes, sleep apnoea, hypertension, and other indications

Ultimately, the best timing may depend on individual preferences and lifestyle